Wedbush maintains a 'Neutral' on Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH), lowers price target from $15 to $12.

Wedbush analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE